Jonathan Bates Net Worth

What's Jonathan Bates's mailing address?

Jonathan's mailing address filed with the SEC is C/O SPRING BANK PHARMACEUTICALS, INC., 86 SOUTH STREET, HOPKINTON, MA, 01748.

Insiders trading at Spring Bank Pharmaceuticals

Over the last 9 years, insiders at Spring Bank Pharmaceuticals have traded over $50,400 worth of Spring Bank Pharmaceuticals stock and bought 237,689 units worth $2,510,768 . The most active insiders traders include Todd C Brady, Scott Andrew Smith y Kurt M Eichler. On average, Spring Bank Pharmaceuticals executives and independent directors trade stock every 38 days with the average trade being worth of $8,517. The most recent stock trade was executed by Garrett Winslow on 19 November 2020, trading 6,250 units of SBPH stock currently worth $7,563.

What does Spring Bank Pharmaceuticals do?

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Spring Bank Pharmaceuticals executives and stock owners

Spring Bank Pharmaceuticals executives and other stock owners filed with the SEC include:

• Kurt M Eichler,
  Director
• Martin J Driscoll,
  President and CEO
• David Arkowitz,
  Director
• Christiana Bardon,
  Director
• Timothy P Clackson,
  Director
• Nezam H. Afdhal,
  Chief Medical Officer
• Todd C Brady,
  Director
• Jonathan Bates,
  Director
• Scott Andrew Smith,
  Director
• Jonathan Freve,
  CFO & Treasurer
• Radhakrishnan P. Iyer,
  Chief Scientific Officer
• Garrett Winslow,
  General Counsel and Secretary
• Pamela M. Klein,
  Director
• Lori Firmani,
  VP of Finance and Treasurer